Nemes Rush Group
WST icon

Nemes Rush Group’s West Pharmaceutical WST Stock Holding History

Nemes Rush Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.23M Buy
+3,312
New +$1.17M 0.1% 95

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return

Nemes Rush Group's WST Position: Q3 2026 in Review

Nemes Rush Group opened a new position in West Pharmaceutical (WST) in Q3 2026: 3,312 shares worth $1.23M. The stake represents 0.1% of the portfolio and ranks #95 among its holdings.

426 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Nemes Rush Group held 3,312 shares of West Pharmaceutical worth $1.23M as of Q3 2026.
  • West Pharmaceutical was a new Nemes Rush Group position in Q3 2026.
  • West Pharmaceutical made up 0.1% of Nemes Rush Group's portfolio in Q3 2026, its #95 holding.
  • 426 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.